ZTS logo

Zoetis Inc.

ZTS
Healthcare|Drug Manufacturers - Specialty & Generic|US
$79.40
-2.71 (-3.30%)
DCF Value
$185.49
Graham Number
$33.02
Cash / Share
$3.72

About

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Stock Price

-33.6%(1Y)
1M
+8.6%
3M
+9.3%
6M
-4.1%
YTD
-36.9%
1Y
-33.7%
3Y
-53.5%
5Y
-63.5%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$32.81B
Employees14,500 (+5% YoY)
CEOKristin C. Peck
IPO DateFeb 1, 2013
Beta0.68
52-Week Range$68.77 – $132.49
Avg Volume5,204,628
ExchangeNYSE
Websitezoetis.com

Ownership

Float99.8%
Shares Outstanding413.2M

Recent Insider Trades

Stetter MarkAWARD
Oct 30, 20265.852 shares
PECK KRISTIN CAWARD
Oct 9, 2026720.144 shares
Esch KevinAWARD
Oct 9, 2026360.073 shares
Driscoll RimmaAWARD
Oct 9, 2026277.772 shares
FULLER JULIEAWARD
Oct 9, 2026367.788 shares

Peers

ELANElanco Animal Health Incorporated
$12.86B
IDXXIDEXX Laboratories, Inc.
$53.26B
MRKMerck & Co., Inc.
$361.96B
NEOGNeogen Corporation
$2.57B
PAHCPhibro Animal Health Corporation
$1.34B
Data last updated: Nov 9, 2026, 04:41 AM